Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study

Abstract

Key message Treatment with pollen allergen specific-immunotherapy improved health-related quality of life in children. Higher symptom scores were associated with lower perceived health-related quality of life. The proportion of children with severe or very severe symptoms from eyes, Nose and/or lungs had significantly decreased after 1 year of pollen SCIT and was maintained during the treatment years

Keywords

• Allergic rhinoconjunctivitis
• DISABKIDS
• Health-related quality of life
• Paediatric population
• Subcutaneous immunotherapy